Preliminary study based on methylation and transcriptome gene sequencing of lncRNAs and immune infiltration in hypopharyngeal carcinoma

Background Hypopharyngeal squamous cell cancer (HSCC) is one of the most malignant tumors of the head and neck. It is not easy to detect in the early stage due to its hidden location; thus, lymph node metastasis is highly likely at diagnosis, leading to a poor prognosis. It is believed that epigenetic modification is related to cancer invasion and metastasis. However, the role of m6A-related lncRNA in the tumor microenvironment (TME) of HSCC remains unclear. Methods The whole transcriptome and methylation sequencing of 5 pairs of HSCC tissues and adjacent tissues were performed to identify the methylation and transcriptome profiles of lncRNAs. The biological significance of lncRNAs differentially expressing the m6A peak was analyzed by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes. By constructing an m6A lncRNA-microRNA network, the mechanism of m6A lncRNAs in HSCC was analyzed. The relative expression levels of selected lncRNAs were examined by quantitative polymerase chain reaction. The CIBERSORT algorithm was used to evaluate the relative proportion of immune cell infiltration in HSCC and paracancerous tissues. Results Based on an in-depth analysis of the sequencing results, 14413 differentially expressed lncRNAs were revealed, including 7329 up-regulated and 7084 down-regulated lncRNAs. Additionally, 4542 up-methylated and 2253 down-methylated lncRNAs were detected. We demonstrated methylation patterns and gene expression profiles of lncRNAs of HSCC transcriptome. In the intersection analysis of lncRNAs and methylated lncRNAs, 51 lncRNAs with up-regulated transcriptome and methylation and 40 lncRNAs with down-regulated transcriptome and methylation were screened, and significantly differentiated lncRNAs were further studied. In the immune cell infiltration analysis, B cell memory was significantly elevated in cancer tissue, while γδT cell amount was significantly decreased. Conclusion m6A modification of lncRNAs might be involved in HSCC pathogenesis. Infiltration of immune cells in HSCC might provide a new direction for its treatment. This study provides new insights for exploring the possible HSCC pathogenesis and searching for new potential therapeutic targets.

[1]  Fei Wang,et al.  Activation of long-non-coding RNA NEAT1 sponging microRNA-147 inhibits radiation damage by targeting PDPK1 in troxerutin radioprotection , 2023, iScience.

[2]  Xuezhi Du,et al.  Novel insight into the functions of N6-methyladenosine modified lncRNAs in cancers (Review) , 2022, International journal of oncology.

[3]  Xiaobing Guo,et al.  DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc , 2022, Mammalian Genome.

[4]  Yan Sun,et al.  Autophagy induction promoted by m6A reader YTHDF3 through translation upregulation of FOXO3 mRNA , 2022, Nature Communications.

[5]  Haibiao Xie,et al.  FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability , 2022, International journal of biological sciences.

[6]  Juze Yang,et al.  LCAT1 is an oncogenic LncRNA by stabilizing the IGF2BP2-CDC6 axis , 2022, Cell Death & Disease.

[7]  YU Peng,et al.  METTL3 contributes to slow transit constipation by regulating miR‐30b‐5p/PIK3R2/Akt/mTOR signaling cascade through DGCR8 , 2022, Journal of gastroenterology and hepatology.

[8]  Jian-zhang Hu,et al.  METTL3 Attenuates Inflammation in Fusarium solani–Induced Keratitis via the PI3K/AKT Signaling Pathway , 2022, Investigative ophthalmology & visual science.

[9]  Xiao-jie He,et al.  The m6A demethylase FTO promotes renal epithelial-mesenchymal transition by reducing the m6A modification of lncRNA GAS5. , 2022, Cytokine.

[10]  Yang Guo,et al.  N6-methyladenosine-mediated upregulation of LINC00520 accelerates breast cancer progression via regulating miR-577/POSTN axis and downstream ILK/AKT/mTOR signaling pathway. , 2022, Archives of biochemistry and biophysics.

[11]  W. Bai,et al.  Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma , 2022, Frontiers in Immunology.

[12]  F. Cheng,et al.  Methyltransferase‐like 3 promotes the progression of lung cancer via activating PI3K/AKT/mTOR pathway , 2022, Clinical and experimental pharmacology & physiology.

[13]  Ronghua Yang,et al.  Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration , 2022, Frontiers in immunology.

[14]  Xiao-ming Meng,et al.  METTL3-mediated m6A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy , 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  Qingliang Wang,et al.  LINC00664/miR-411-5p/KLF9 feedback loop contributes to the human oral squamous cell carcinoma progression. , 2021, Oral diseases.

[16]  C. Maher,et al.  Long noncoding RNAs in cancer metastasis , 2021, Nature Reviews Cancer.

[17]  Maite Huarte,et al.  Gene regulation by long non-coding RNAs and its biological functions , 2020, Nature reviews. Molecular cell biology.

[18]  Xiaoyu Chen,et al.  Novel insights into the interplay between m6A modification and noncoding RNAs in cancer , 2020, Molecular Cancer.

[19]  M. Simon,et al.  The tumor microenvironment , 2020, Current Biology.

[20]  Noam Stern-Ginossar,et al.  The RNA modification N6-methyladenosine as a novel regulator of the immune system , 2020, Nature Immunology.

[21]  A. Shiotani,et al.  Transoral videolaryngoscopic surgery for laryngeal and hypopharyngeal cancer - Technical updates and long-term results. , 2020, Auris, nasus, larynx.

[22]  Fei Liu,et al.  Oncologic Outcomes of Patients With Sarcomatoid Carcinoma of the Hypopharynx , 2019, Front. Oncol..

[23]  Y. Liu,et al.  Down‐regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA‐145‐mediated inhibition of FSCN1 , 2019, Molecular oncology.

[24]  K. Matsuura,et al.  Surgical management around the paratracheal area of hypopharyngeal cancer , 2019, Japanese journal of clinical oncology.

[25]  Ash A. Alizadeh,et al.  Determining cell-type abundance and expression from bulk tissues with digital cytometry , 2019, Nature Biotechnology.

[26]  C. Tsatsanis,et al.  Regulation of Endotoxin Tolerance and Compensatory Anti-inflammatory Response Syndrome by Non-coding RNAs , 2018, Front. Immunol..

[27]  Stefan Hüttelmaier,et al.  Recognition of RNA N6-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation , 2018, Nature Cell Biology.

[28]  Yun-Gui Yang,et al.  Cytoplasmic m6A reader YTHDF3 promotes mRNA translation , 2017, Cell Research.

[29]  Jacques Ferlay,et al.  The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012 , 2017, CA: a cancer journal for clinicians.

[30]  Ping Wang,et al.  Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. , 2016, Molecular cell.

[31]  B. Das,et al.  N6‐methyladenosine modification in mRNA: machinery, function and implications for health and diseases , 2016, The FEBS journal.

[32]  Ioana Berindan-Neagoe,et al.  Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma , 2016, International journal of molecular sciences.

[33]  Xiaoshen Wang,et al.  Multi-modality management for loco-regionally advanced laryngeal and hypopharyngeal cancer: balancing the benefit of efficacy and functional preservation , 2014, Medical Oncology.

[34]  Arne Klungland,et al.  ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. , 2013, Molecular cell.

[35]  M. Kupiec,et al.  Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq , 2012, Nature.

[36]  Chengqi Yi,et al.  N6-Methyladenosine in Nuclear RNA is a Major Substrate of the Obesity-Associated FTO , 2011, Nature chemical biology.